

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.28392630 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.17930680 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.10158751 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.10158751 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.10158751 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.10158751 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.10158751 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.10158751 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 5.09939551 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.86707957 |
| 11 | response to peptidoglycan (GO:0032494) | 4.74770864 |
| 12 | cellular extravasation (GO:0045123) | 4.44931823 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34692474 |
| 14 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.30301879 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 4.20126511 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.07235245 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.01300953 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 4.01248701 |
| 19 | response to muramyl dipeptide (GO:0032495) | 3.96666393 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.85671882 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.77171375 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.74899715 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.72284296 |
| 24 | neutrophil mediated immunity (GO:0002446) | 3.71641005 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.65667743 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65667743 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.63132541 |
| 28 | response to host immune response (GO:0052572) | 3.58615100 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.58615100 |
| 30 | microglial cell activation (GO:0001774) | 3.55288275 |
| 31 | germinal center formation (GO:0002467) | 3.52309263 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.50495733 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50433937 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.50397702 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.41127835 |
| 36 | response to host (GO:0075136) | 3.39668539 |
| 37 | response to host defenses (GO:0052200) | 3.39668539 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39668539 |
| 39 | negative T cell selection (GO:0043383) | 3.38006434 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37167583 |
| 41 | detection of other organism (GO:0098543) | 3.36752395 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.36518512 |
| 43 | macrophage activation (GO:0042116) | 3.36082569 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.35378836 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 3.34125481 |
| 46 | T cell migration (GO:0072678) | 3.31937828 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28724783 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26078069 |
| 49 | cell wall macromolecule catabolic process (GO:0016998) | 3.25732290 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.24183731 |
| 51 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21855525 |
| 52 | interferon-gamma production (GO:0032609) | 3.19618080 |
| 53 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16920673 |
| 54 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.16136004 |
| 55 | I-kappaB phosphorylation (GO:0007252) | 3.15391398 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 3.13126173 |
| 57 | myeloid leukocyte mediated immunity (GO:0002444) | 3.12766836 |
| 58 | positive thymic T cell selection (GO:0045059) | 3.08454495 |
| 59 | response to interleukin-15 (GO:0070672) | 3.07241440 |
| 60 | positive regulation of interferon-beta production (GO:0032728) | 3.03938835 |
| 61 | defense response to protozoan (GO:0042832) | 3.03446351 |
| 62 | regulation of B cell differentiation (GO:0045577) | 3.03267829 |
| 63 | hepatocyte apoptotic process (GO:0097284) | 3.02488367 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01091154 |
| 65 | cellular response to ethanol (GO:0071361) | 2.99508215 |
| 66 | dosage compensation (GO:0007549) | 2.98967308 |
| 67 | response to protozoan (GO:0001562) | 2.97272061 |
| 68 | pinocytosis (GO:0006907) | 2.97052655 |
| 69 | neutrophil activation (GO:0042119) | 2.91596506 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.91583338 |
| 71 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.90963018 |
| 72 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.89718680 |
| 73 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89154901 |
| 74 | regulation of necroptotic process (GO:0060544) | 2.88639897 |
| 75 | B cell homeostasis (GO:0001782) | 2.86780094 |
| 76 | respiratory burst (GO:0045730) | 2.85788225 |
| 77 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.85308470 |
| 78 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.83917638 |
| 79 | myeloid leukocyte activation (GO:0002274) | 2.77281653 |
| 80 | detection of bacterium (GO:0016045) | 2.77102582 |
| 81 | myeloid dendritic cell activation (GO:0001773) | 2.75904372 |
| 82 | regulation of interferon-beta production (GO:0032648) | 2.75705958 |
| 83 | granulocyte activation (GO:0036230) | 2.73717705 |
| 84 | positive T cell selection (GO:0043368) | 2.73218020 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70138933 |
| 86 | leukocyte degranulation (GO:0043299) | 2.70040317 |
| 87 | negative regulation of B cell proliferation (GO:0030889) | 2.69599462 |
| 88 | regulation of macrophage cytokine production (GO:0010935) | 2.69369457 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68170507 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 2.67107607 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66536891 |
| 92 | positive regulation of macrophage cytokine production (GO:0060907) | 2.66239013 |
| 93 | regulation of B cell proliferation (GO:0030888) | 2.66153958 |
| 94 | mast cell activation (GO:0045576) | 2.64690250 |
| 95 | positive regulation of granulocyte differentiation (GO:0030854) | 2.64129104 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.63238077 |
| 97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62422778 |
| 98 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.59370445 |
| 99 | regulation of mast cell degranulation (GO:0043304) | 2.58618703 |
| 100 | embryonic process involved in female pregnancy (GO:0060136) | 2.57625695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73183002 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.34803964 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.76850484 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55497791 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54272138 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35833121 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.27611045 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.25085404 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.09514267 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.94843070 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.90664240 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87409142 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.76296377 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.74708007 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67077403 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.60913003 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58655530 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.53856975 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44430204 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41449666 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.36219413 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35215806 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.34106140 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33275481 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31048955 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29453061 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23960095 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20406066 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19696618 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.15231813 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11333068 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10495169 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06141974 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.04254270 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93695279 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93082628 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84517364 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84250910 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83745434 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82914661 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.77121280 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76470062 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.76058634 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73595132 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73009918 |
| 46 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.71997621 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71678070 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.60058699 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59585210 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.57279706 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51256479 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49246750 |
| 53 | GATA2_19941826_ChIP-Seq_K562_Human | 1.48114529 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48022642 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45530324 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38047700 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37129555 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37109498 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35392844 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32742207 |
| 61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30850388 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.30023170 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22731502 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22591651 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20408500 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19788714 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19302560 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15770851 |
| 69 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14337061 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12494295 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10392785 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09976927 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06220939 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03856321 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03337733 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02088650 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01029139 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00156661 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99232323 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96793296 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95654301 |
| 82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.92564983 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88878345 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88043635 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87933294 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85993060 |
| 87 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85854055 |
| 88 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85213751 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84129115 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83750838 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83731030 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83302779 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82740530 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81564196 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79625289 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.79444383 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79430438 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78849657 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77979704 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76792205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.69895228 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.42244169 |
| 3 | MP0000685_abnormal_immune_system | 3.06265921 |
| 4 | MP0003436_decreased_susceptibility_to | 3.01951122 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.85125260 |
| 6 | MP0003724_increased_susceptibility_to | 2.74185097 |
| 7 | MP0001800_abnormal_humoral_immune | 2.74104380 |
| 8 | MP0002419_abnormal_innate_immunity | 2.63882347 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.59042858 |
| 10 | MP0008057_abnormal_DNA_replication | 2.56791082 |
| 11 | MP0008260_abnormal_autophagy | 2.50067819 |
| 12 | MP0005671_abnormal_response_to | 2.46715112 |
| 13 | MP0002723_abnormal_immune_serum | 2.39081580 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.36059327 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.35336306 |
| 16 | MP0005025_abnormal_response_to | 2.33212151 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.27356298 |
| 18 | MP0001819_abnormal_immune_cell | 2.24460688 |
| 19 | MP0005387_immune_system_phenotype | 2.22729708 |
| 20 | MP0001790_abnormal_immune_system | 2.22729708 |
| 21 | MP0005451_abnormal_body_composition | 2.21257330 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.16988746 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.16963826 |
| 24 | MP0009785_altered_susceptibility_to | 2.15866814 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.14915798 |
| 26 | MP0002398_abnormal_bone_marrow | 2.03727812 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.03712660 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.99968704 |
| 29 | MP0000716_abnormal_immune_system | 1.87581043 |
| 30 | MP0002405_respiratory_system_inflammati | 1.86871510 |
| 31 | MP0004947_skin_inflammation | 1.84103239 |
| 32 | MP0001853_heart_inflammation | 1.83473652 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.83408620 |
| 34 | MP0002006_tumorigenesis | 1.71973688 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.69949056 |
| 36 | MP0002722_abnormal_immune_system | 1.69228028 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.65699124 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.65699124 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.65336432 |
| 40 | MP0002429_abnormal_blood_cell | 1.60966188 |
| 41 | MP0006082_CNS_inflammation | 1.59214705 |
| 42 | MP0000858_altered_metastatic_potential | 1.58041396 |
| 43 | MP0009278_abnormal_bone_marrow | 1.57883250 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.55790942 |
| 45 | MP0004381_abnormal_hair_follicle | 1.53001073 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.52091963 |
| 47 | MP0003828_pulmonary_edema | 1.48100517 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.46706785 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.46559801 |
| 50 | MP0002132_abnormal_respiratory_system | 1.43902120 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.39318067 |
| 52 | MP0009764_decreased_sensitivity_to | 1.35170622 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.34814671 |
| 54 | MP0004510_myositis | 1.31957268 |
| 55 | MP0005310_abnormal_salivary_gland | 1.28072966 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.27051687 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.26750913 |
| 58 | MP0004883_abnormal_blood_vessel | 1.24943704 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22786525 |
| 60 | MP0008469_abnormal_protein_level | 1.19705411 |
| 61 | MP0005164_abnormal_response_to | 1.11064426 |
| 62 | MP0003866_abnormal_defecation | 1.10857288 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.05447970 |
| 64 | MP0002009_preneoplasia | 1.04865382 |
| 65 | MP0000371_diluted_coat_color | 1.03999131 |
| 66 | MP0003091_abnormal_cell_migration | 1.03103611 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.02810079 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.01374658 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.01193031 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.01047151 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.99027799 |
| 72 | MP0003075_altered_response_to | 0.95843624 |
| 73 | MP0009763_increased_sensitivity_to | 0.95701881 |
| 74 | MP0001851_eye_inflammation | 0.94767273 |
| 75 | MP0002019_abnormal_tumor_incidence | 0.94459976 |
| 76 | MP0000609_abnormal_liver_physiology | 0.93529389 |
| 77 | MP0006054_spinal_hemorrhage | 0.92356270 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.89808438 |
| 79 | MP0005621_abnormal_cell_physiology | 0.82801245 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.81422015 |
| 81 | MP0003252_abnormal_bile_duct | 0.78602627 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.75868649 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.75795465 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.74773349 |
| 85 | MP0003045_fibrosis | 0.73224494 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.72534973 |
| 87 | MP0000604_amyloidosis | 0.71686267 |
| 88 | MP0001915_intracranial_hemorrhage | 0.70927601 |
| 89 | MP0005408_hypopigmentation | 0.70387934 |
| 90 | MP0010307_abnormal_tumor_latency | 0.68913341 |
| 91 | MP0000249_abnormal_blood_vessel | 0.68810589 |
| 92 | MP0003448_altered_tumor_morphology | 0.67443025 |
| 93 | MP0009115_abnormal_fat_cell | 0.66146876 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.63061469 |
| 95 | MP0004147_increased_porphyrin_level | 0.63033942 |
| 96 | MP0005384_cellular_phenotype | 0.62956025 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.61156776 |
| 98 | MP0003195_calcinosis | 0.61074138 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.60682720 |
| 100 | MP0003690_abnormal_glial_cell | 0.59343109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.83943411 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.56569094 |
| 3 | Optic neuritis (HP:0100653) | 4.56569094 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.33283192 |
| 5 | Orchitis (HP:0100796) | 4.30379115 |
| 6 | Myositis (HP:0100614) | 4.08932797 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.93523608 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.89143716 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.79515197 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.73580908 |
| 11 | Keratoconjunctivitis sicca (HP:0001097) | 3.72482691 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.72193057 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.71782153 |
| 14 | Recurrent viral infections (HP:0004429) | 3.70555821 |
| 15 | Meningitis (HP:0001287) | 3.60641724 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59033228 |
| 17 | Colitis (HP:0002583) | 3.55133987 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.53384259 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.53384259 |
| 20 | Vasculitis (HP:0002633) | 3.53258157 |
| 21 | Recurrent skin infections (HP:0001581) | 3.49411753 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.45488252 |
| 23 | Arterial thrombosis (HP:0004420) | 3.34125812 |
| 24 | Keratoconjunctivitis (HP:0001096) | 3.32501313 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.25603334 |
| 26 | Gingival bleeding (HP:0000225) | 3.21471668 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.19165089 |
| 28 | Viral hepatitis (HP:0006562) | 3.17246581 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.11641121 |
| 30 | Encephalitis (HP:0002383) | 3.04483524 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.01449107 |
| 32 | T lymphocytopenia (HP:0005403) | 3.00637173 |
| 33 | Fatigue (HP:0012378) | 2.95235196 |
| 34 | Stomatitis (HP:0010280) | 2.91977387 |
| 35 | Abnormality of T cells (HP:0002843) | 2.90023274 |
| 36 | Cellulitis (HP:0100658) | 2.89464664 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.87409944 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.82556034 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.81571877 |
| 40 | Abnormality of the peritoneum (HP:0002585) | 2.76069116 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74554767 |
| 42 | Obstructive lung disease (HP:0006536) | 2.74554767 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.74135136 |
| 44 | Deep venous thrombosis (HP:0002625) | 2.73196515 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.70665829 |
| 46 | IgA deficiency (HP:0002720) | 2.67134272 |
| 47 | Epistaxis (HP:0000421) | 2.64512722 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.63746670 |
| 49 | Granulocytopenia (HP:0001913) | 2.62253235 |
| 50 | Gangrene (HP:0100758) | 2.60407318 |
| 51 | Myocardial infarction (HP:0001658) | 2.55828240 |
| 52 | Chest pain (HP:0100749) | 2.53220653 |
| 53 | Gingivitis (HP:0000230) | 2.49028134 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.48739183 |
| 55 | Leukocytosis (HP:0001974) | 2.46418760 |
| 56 | Urticaria (HP:0001025) | 2.46386411 |
| 57 | Amyloidosis (HP:0011034) | 2.45380344 |
| 58 | Subacute progressive viral hepatitis (HP:0006572) | 2.44842576 |
| 59 | Episodic fever (HP:0001954) | 2.44092801 |
| 60 | Pustule (HP:0200039) | 2.41507166 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.41390988 |
| 62 | Peritonitis (HP:0002586) | 2.40993816 |
| 63 | Thrombophlebitis (HP:0004418) | 2.40222934 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39897593 |
| 65 | Osteomyelitis (HP:0002754) | 2.36001151 |
| 66 | Hemoptysis (HP:0002105) | 2.35613426 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.34978091 |
| 68 | Acute hepatic failure (HP:0006554) | 2.31988772 |
| 69 | Pulmonary embolism (HP:0002204) | 2.30309316 |
| 70 | Glomerulopathy (HP:0100820) | 2.26596938 |
| 71 | Lymphopenia (HP:0001888) | 2.21351408 |
| 72 | Poikilocytosis (HP:0004447) | 2.19863730 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18648370 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.15799803 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.15553786 |
| 76 | Anorexia (HP:0002039) | 2.15003879 |
| 77 | Eosinophilia (HP:0001880) | 2.12653713 |
| 78 | Somatic mutation (HP:0001428) | 2.09976826 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.09433365 |
| 80 | Recurrent bronchitis (HP:0002837) | 2.08442799 |
| 81 | Thrombocytosis (HP:0001894) | 2.08269996 |
| 82 | Increased serum ferritin (HP:0003281) | 2.04040030 |
| 83 | Acanthocytosis (HP:0001927) | 2.00834839 |
| 84 | IgM deficiency (HP:0002850) | 1.99976666 |
| 85 | Chronic diarrhea (HP:0002028) | 1.99540490 |
| 86 | Increased IgE level (HP:0003212) | 1.99519276 |
| 87 | Abnormal platelet function (HP:0011869) | 1.98865994 |
| 88 | Impaired platelet aggregation (HP:0003540) | 1.98865994 |
| 89 | IgG deficiency (HP:0004315) | 1.98657427 |
| 90 | Sepsis (HP:0100806) | 1.97562192 |
| 91 | Keratitis (HP:0000491) | 1.94444149 |
| 92 | Menorrhagia (HP:0000132) | 1.94305227 |
| 93 | Abnormality of the endocardium (HP:0004306) | 1.93099263 |
| 94 | Recurrent sinusitis (HP:0011108) | 1.91742773 |
| 95 | Skin ulcer (HP:0200042) | 1.86343444 |
| 96 | Submucous cleft hard palate (HP:0000176) | 1.85507250 |
| 97 | Amaurosis fugax (HP:0100576) | 1.84517181 |
| 98 | Hepatitis (HP:0012115) | 1.83848680 |
| 99 | Arthralgia (HP:0002829) | 1.83822572 |
| 100 | Periodontitis (HP:0000704) | 1.83429847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.59373579 |
| 2 | TXK | 3.48896822 |
| 3 | MAP3K14 | 2.96810825 |
| 4 | IKBKE | 2.81273393 |
| 5 | PRPF4B | 2.73326243 |
| 6 | IRAK4 | 2.70305715 |
| 7 | CDK12 | 2.39000268 |
| 8 | BLK | 2.33060705 |
| 9 | IRAK3 | 2.29362053 |
| 10 | MAP4K1 | 2.28618094 |
| 11 | BMPR2 | 2.17257440 |
| 12 | MAP2K3 | 2.04069930 |
| 13 | TYK2 | 1.83914170 |
| 14 | CSK | 1.79945320 |
| 15 | SYK | 1.78523737 |
| 16 | IRAK1 | 1.66232709 |
| 17 | WNK1 | 1.64041829 |
| 18 | FGFR3 | 1.63700343 |
| 19 | FGR | 1.60208206 |
| 20 | IRAK2 | 1.52833712 |
| 21 | STK10 | 1.51508074 |
| 22 | JAK1 | 1.50037202 |
| 23 | TBK1 | 1.49147049 |
| 24 | ZAP70 | 1.47950486 |
| 25 | TAOK3 | 1.43100791 |
| 26 | TGFBR2 | 1.38402539 |
| 27 | MATK | 1.38073262 |
| 28 | JAK3 | 1.37410817 |
| 29 | BTK | 1.34779580 |
| 30 | MAP3K13 | 1.34691040 |
| 31 | FGFR4 | 1.33732830 |
| 32 | SIK2 | 1.33493458 |
| 33 | IKBKB | 1.31200006 |
| 34 | GRK6 | 1.30448677 |
| 35 | JAK2 | 1.21482627 |
| 36 | GRK7 | 1.17525243 |
| 37 | HCK | 1.16282148 |
| 38 | MOS | 1.11902447 |
| 39 | LYN | 1.11453187 |
| 40 | ITK | 1.10224890 |
| 41 | CSF1R | 1.10202819 |
| 42 | PIK3CG | 1.05997237 |
| 43 | RAF1 | 1.04522982 |
| 44 | MAP3K2 | 1.04336831 |
| 45 | KIT | 1.04296852 |
| 46 | TRPM7 | 1.02200620 |
| 47 | CHUK | 1.01771510 |
| 48 | PDK1 | 1.00380400 |
| 49 | KSR2 | 0.94094974 |
| 50 | FES | 0.93217646 |
| 51 | TESK2 | 0.91931620 |
| 52 | PIM1 | 0.90366214 |
| 53 | LCK | 0.89793058 |
| 54 | ERN1 | 0.89490915 |
| 55 | TEC | 0.88938187 |
| 56 | NEK9 | 0.88047242 |
| 57 | MAPK11 | 0.81953635 |
| 58 | STK24 | 0.81491535 |
| 59 | YES1 | 0.78146246 |
| 60 | MARK3 | 0.77828068 |
| 61 | EIF2AK1 | 0.76751693 |
| 62 | CDK4 | 0.76710668 |
| 63 | MAP3K1 | 0.74282618 |
| 64 | BRD4 | 0.73282991 |
| 65 | TAOK2 | 0.72735915 |
| 66 | CAMK1D | 0.71537316 |
| 67 | MAP3K6 | 0.68871620 |
| 68 | PDPK1 | 0.67151839 |
| 69 | CDC42BPA | 0.65707120 |
| 70 | RPS6KB2 | 0.64656800 |
| 71 | PRKCQ | 0.62523300 |
| 72 | MAP3K5 | 0.60181543 |
| 73 | MELK | 0.58484705 |
| 74 | SGK3 | 0.52970290 |
| 75 | SGK2 | 0.52396125 |
| 76 | EIF2AK3 | 0.50150425 |
| 77 | PIK3CA | 0.48064498 |
| 78 | RET | 0.47908862 |
| 79 | STK4 | 0.46926024 |
| 80 | ACVR1B | 0.46759377 |
| 81 | TRIB3 | 0.46624484 |
| 82 | CAMKK2 | 0.46513207 |
| 83 | SIK3 | 0.44947734 |
| 84 | PDK2 | 0.41413394 |
| 85 | MAPK12 | 0.40610962 |
| 86 | MAP3K3 | 0.40592662 |
| 87 | CDK6 | 0.39093818 |
| 88 | HIPK2 | 0.37795135 |
| 89 | GRK5 | 0.36407595 |
| 90 | MARK2 | 0.36285082 |
| 91 | MAP3K8 | 0.35437349 |
| 92 | ARAF | 0.34939546 |
| 93 | MAPKAPK2 | 0.34639030 |
| 94 | SGK1 | 0.34449499 |
| 95 | LRRK2 | 0.34350777 |
| 96 | MAPK7 | 0.33474193 |
| 97 | STK16 | 0.30347103 |
| 98 | AKT3 | 0.29949220 |
| 99 | EGFR | 0.29888412 |
| 100 | EIF2AK2 | 0.29762925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81109240 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69849560 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.67954610 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42026126 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39724858 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20296756 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13714817 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.05373864 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01698150 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97538948 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.89399369 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86417037 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.84017352 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82061241 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81776255 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.81774809 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.81137474 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.79446223 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75486837 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74213483 |
| 21 | Hepatitis B_Homo sapiens_hsa05161 | 1.70218935 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65959045 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65919830 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.64972170 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.62004650 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59675699 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57587378 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55043688 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.53081658 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49735687 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.44574416 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42059268 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41805388 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41357084 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38056464 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.35962466 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.31530443 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29882366 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29827583 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21160560 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19187378 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18268883 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15648428 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13953741 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12131162 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09869968 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.09351582 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08863937 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.06091939 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05467721 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03244377 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 1.01859341 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98578421 |
| 54 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.96497175 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95446055 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94416925 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94179594 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.92631813 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90854262 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89237642 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82383750 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82311674 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.81110550 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.80258709 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78926162 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78811903 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77417704 |
| 68 | Prostate cancer_Homo sapiens_hsa05215 | 0.75787168 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75348415 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74587440 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74443517 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73994467 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72045535 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69935912 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67418150 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.66972296 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65674170 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62788750 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62752410 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.61467172 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60886054 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56314847 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54788011 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53640107 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52878045 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.49244792 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48360184 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48285201 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46245627 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46125782 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43995583 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.43124707 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.38854345 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38441832 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35706818 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35153414 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34249061 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34028415 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32927939 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32115490 |

